28 related articles for article (PubMed ID: 10770643)
1. Interferon-alpha and interleukin-12 gene therapy of cancer: interferon-alpha induces tumor-specific immune responses while interleukin-12 stimulates non-specific killing.
Eguchi J; Hiroishi K; Ishii S; Mitamura K
Cancer Immunol Immunother; 2003 Jun; 52(6):378-86. PubMed ID: 12739068
[TBL] [Abstract][Full Text] [Related]
2. Suppression of tumorigenicity and metastasis in murine UV-2237 fibrosarcoma cells by infection with a retroviral vector harboring the interferon-beta gene.
Dong Z; Juang SH; Kumar R; Eue I; Xie K; Bielenberg D; Lu W; Bucana C; Yang X; Fidler IJ
Cancer Immunol Immunother; 1998 May; 46(3):137-46. PubMed ID: 9625537
[TBL] [Abstract][Full Text] [Related]
3. Complete tumour regressions induced by vaccination with IL-12 gene-transduced tumour cells in combination with IL-15 in a melanoma model in mice.
Lasek W; Basak G; Switaj T; Jakubowska AB; Wysocki PJ; Mackiewicz A; Drela N; Jalili A; Kamiński R; Kozar K; Jakóbisiak M
Cancer Immunol Immunother; 2004 Apr; 53(4):363-72. PubMed ID: 14605763
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived interleukin (IL)-6 induced anti-tumor effect in immune-compromised hosts.
Ishiguro H; Kishimoto T; Furuya M; Nagai Y; Watanabe T; Ishikura H
Cancer Immunol Immunother; 2005 Dec; 54(12):1191-9. PubMed ID: 15846489
[TBL] [Abstract][Full Text] [Related]
5. Vaccination effect of interleukin-6-producing pancreatic cancer cells in nude mice: a model of tumor prevention and treatment in immune-compromised patients.
Yano T; Ishikura H; Kato H; Ogawa Y; Kondo S; Kato H; Yoshiki T
Jpn J Cancer Res; 2001 Jan; 92(1):83-7. PubMed ID: 11173548
[TBL] [Abstract][Full Text] [Related]
6. Intricacies for posttranslational tumor-targeted cytokine gene therapy.
Cutrera J; Dibra D; Satelli A; Xia X; Li S
Mediators Inflamm; 2013; 2013():378971. PubMed ID: 24369443
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of obesity- and diabetes mellitus-related pancreatic carcinogenesis: a comprehensive and systematic review.
Ruze R; Song J; Yin X; Chen Y; Xu R; Wang C; Zhao Y
Signal Transduct Target Ther; 2023 Mar; 8(1):139. PubMed ID: 36964133
[TBL] [Abstract][Full Text] [Related]
8. Chronic Pancreatitis and the Development of Pancreatic Cancer.
Kandikattu HK; Venkateshaiah SU; Mishra A
Endocr Metab Immune Disord Drug Targets; 2020; 20(8):1182-1210. PubMed ID: 32324526
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic ductal adenocarcinoma immune microenvironment and immunotherapy prospects.
Li KY; Yuan JL; Trafton D; Wang JX; Niu N; Yuan CH; Liu XB; Zheng L
Chronic Dis Transl Med; 2020 Mar; 6(1):6-17. PubMed ID: 32226930
[TBL] [Abstract][Full Text] [Related]
10. IL-15 regulates fibrosis and inflammation in a mouse model of chronic pancreatitis.
Manohar M; Kandikattu HK; Verma AK; Mishra A
Am J Physiol Gastrointest Liver Physiol; 2018 Dec; 315(6):G954-G965. PubMed ID: 30212254
[TBL] [Abstract][Full Text] [Related]
11. Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer.
D'Cruz OJ; Qazi S; Hwang L; Ng K; Trieu V
Onco Targets Ther; 2018; 11():2779-2796. PubMed ID: 29785126
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells.
Van Audenaerde JRM; De Waele J; Marcq E; Van Loenhout J; Lion E; Van den Bergh JMJ; Jesenofsky R; Masamune A; Roeyen G; Pauwels P; Lardon F; Peeters M; Smits ELJ
Oncotarget; 2017 Aug; 8(34):56968-56979. PubMed ID: 28915646
[TBL] [Abstract][Full Text] [Related]
13. Transduction of murine colon carcinoma cells with interleukin-15 gene induces antitumor effects in immunocompetent and immunocompromised hosts.
Tasaki K; Yoshida Y; Miyauchi M; Maeda T; Takenaga K; Kouzu T; Asano T; Ochiai T; Sakiyamna S; Tagawa M
Cancer Gene Ther; 2000 Feb; 7(2):255-61. PubMed ID: 10770634
[TBL] [Abstract][Full Text] [Related]
14. Transduction of the IL-21 and IL-23 genes in human pancreatic carcinoma cells produces natural killer cell-dependent and -independent antitumor effects.
Ugai S; Shimozato O; Yu L; Wang YQ; Kawamura K; Yamamoto H; Yamaguchi T; Saisho H; Sakiyama S; Tagawa M
Cancer Gene Ther; 2003 Oct; 10(10):771-8. PubMed ID: 14502230
[TBL] [Abstract][Full Text] [Related]
15. Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells.
Tasaki K; Yoshida Y; Maeda T; Miyauchi M; Kawamura K; Takenaga K; Yamamoto H; Kouzu T; Asano T; Ochiai T; Sakiyama S; Tagawa M
Cancer Gene Ther; 2000 Feb; 7(2):247-54. PubMed ID: 10770633
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect of human pancreatic cancer cells transduced with cytokine genes which activate Th1 helper T cells.
Yoshida Y; Tasaki K; Kimurai M; Takenaga K; Yamamoto H; Yamaguchi T; Saisho H; Sakiyama S; Tagawa M
Anticancer Res; 1998; 18(1A):333-5. PubMed ID: 9568099
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer gene therapy: transgenic immunotherapy.
Su N; Ojeifo JO; MacPherson A; Zwiebel JA
Breast Cancer Res Treat; 1994; 31(2-3):349-56. PubMed ID: 7881111
[TBL] [Abstract][Full Text] [Related]
18. Impaired tumorigenicity of human pancreatic cancer cells retrovirally transduced with interleukin-12 or interleukin-15 gene.
Yoshida Y; Tasaki K; Miyauchi M; Narita M; Takenaga K; Yamamoto H; Yaaguchi T; Saisho H; Sakiyama S; Tagawa M
Cancer Gene Ther; 2000 Feb; 7(2):324-31. PubMed ID: 10770643
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
